Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · IEX Real-Time Price · USD
67.56
+1.16 (1.75%)
May 7, 2024, 3:39 PM EDT - Market open
Vaxcyte Employees
Vaxcyte had 254 employees on December 31, 2023. The number of employees increased by 96 or 60.76% compared to the previous year.
Employees
254
Change (1Y)
96
Growth (1Y)
60.76%
Revenue / Employee
n/a
Profits / Employee
-$1,583,724
Market Cap
7.35B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 254 | 96 | 60.76% |
Dec 31, 2022 | 158 | 69 | 77.53% |
Dec 31, 2021 | 89 | 31 | 53.45% |
Dec 31, 2020 | 58 | 15 | 34.88% |
Dec 31, 2019 | 43 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Bio-Rad Laboratories | 8,030 |
Globus Medical | 5,000 |
Masimo | 3,800 |
HealthEquity | 3,150 |
Jazz Pharmaceuticals | 2,800 |
Inspire Medical Systems | 1,011 |
Ascendis Pharma | 879 |
Cytokinetics | 423 |
PCVX News
- 4 weeks ago - Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants - GlobeNewsWire
- 2 months ago - Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 - GlobeNewsWire
- 3 months ago - Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 3 months ago - Vaxcyte to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference - GlobeNewsWire
- 3 months ago - Vaxcyte Announces Pricing of $750 Million Public Offering - GlobeNewsWire
- 3 months ago - Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire